These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8473380)

  • 21. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercortisolism in patients with functional hypothalamic-amenorrhea.
    Suh BY; Liu JH; Berga SL; Quigley ME; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1988 Apr; 66(4):733-9. PubMed ID: 3346352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplitude suppression of the pulsatile mode of immunoradiometric luteinizing hormone release in fasting-induced hypoandrogenemia in normal men.
    Veldhuis JD; Iranmanesh A; Evans WS; Lizarralde G; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1993 Mar; 76(3):587-93. PubMed ID: 8445014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
    Luboshitzky R; Lavi S; Thuma I; Lavie P
    J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol amplifies the amount of luteinizing hormone (LH) secreted in response to increasing doses of gonadotropin-releasing hormone by specifically augmenting the duration of evoked LH secretory events and hence their mass.
    Quyyumi SA; Pinkerton JV; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 1993 Mar; 76(3):594-600. PubMed ID: 8445015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of testosterone infusion and naloxone on luteinizing hormone secretion in normal men.
    Kletter GB; Foster CM; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1215-9. PubMed ID: 1430081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women.
    Loucks AB; Mortola JF; Girton L; Yen SS
    J Clin Endocrinol Metab; 1989 Feb; 68(2):402-11. PubMed ID: 2537332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of gonadotropin secretion in the ovine fetus: the effects of a specific gonadotropin-releasing hormone antagonist on pulsatile luteinizing hormone secretion.
    Matwijiw I; Faiman C
    Endocrinology; 1987 Jul; 121(1):347-51. PubMed ID: 3297644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus.
    Asplin CM; Faria AC; Carlsen EC; Vaccaro VA; Barr RE; Iranmanesh A; Lee MM; Veldhuis JD; Evans WS
    J Clin Endocrinol Metab; 1989 Aug; 69(2):239-45. PubMed ID: 2753972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
    Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute androgen receptor blockade increases luteinizing hormone secretory activity in men.
    Urban RJ; Davis MR; Rogol AD; Johnson ML; Veldhuis JD
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1149-55. PubMed ID: 3056968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential responses of biologically active luteinizing hormone secretion in older versus young men to interruption of androgen negative feedback.
    Veldhuis JD; Urban RJ; Dufau ML
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1763-70. PubMed ID: 7989483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.